Can transcranial ultrasound and microbubble therapy ever enter the mainstream in acute stroke therapy?

@article{Porter2012CanTU,
  title={Can transcranial ultrasound and microbubble therapy ever enter the mainstream in acute stroke therapy?},
  author={Thomas R. Porter and Feng Xie},
  journal={Expert review of cardiovascular therapy},
  year={2012},
  volume={10 5},
  pages={549-51}
}
Ischemic stroke remains the third most common cause of death in the USA. It is a leading cause of long-term major disability and approximately 700,000 new cases are recorded every year. Despite numerous Phase II and III clinical trials evaluating potential therapies, there is currently only one accepted treatment: tissue plasminogen activator (tPA) [1… CONTINUE READING